A Randomised Trial Evaluating Continuous Subcutaneous Infusion of Formulations of NN1218 and NovoLog® in Subjects With Type 1 Diabetes

Update Il y a 4 ans
Reference: NCT01682902

Woman and Man

Extract

This trial is conducted in the United States of America (USA). The aim of the trial is to evaluate continuous subcutaneous infusion of NN1218 formulations and NovoLog® in subjects with type 1 diabetes.


Inclusion criteria

  • diabetes ,Diabetes Mellitus, Type 1

Links